Author: Xiaoyong Zhong#1, Xinghui Yan#2, Hui Liang1, Rui Xia3, Bin Chen4, Hong-Jia Zhao5
Affiliation: <sup>1</sup> Department of Neurology, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.
<sup>2</sup> Department of Physical Education, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
<sup>3</sup> College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
<sup>4</sup> Department of Rehabilitation, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.
<sup>5</sup> The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China hongjiafz@163.com.
Conference/Journal: BMJ Open
Date published: 2021 Feb 8
Other:
Volume ID: 11 , Issue ID: 2 , Pages: e042177 , Special Notes: doi: 10.1136/bmjopen-2020-042177. , Word Count: 305
Introduction:
Cerebral small vessel disease (CSVD) is a critical factor that causes cognitive decline and progresses to vascular dementia and acute cerebrovascular events. Tai chi has been proven to improve nerve plasticity formation and directly improve cognitive function compared with other sports therapy, which has shown its unique advantages. However, more medical evidence needs to be collected in order to verify that Tai chi exercises can improve cognitive impairment due to CSVD. The main purposes of this study are to investigate the effect of Tai chi exercise on neuropsychological outcomes of patients with cognitive impairment related to CSVD and to explore its mechanism of action with neuroimaging, including functional MRI (fMRI) and event-related potential (P300).
Methods and analysis:
The design of this study is a randomised controlled trial with two parallel groups in a 1:1 allocation ratio with allocation concealment and assessor blinding. A total of 106 participants will be enrolled and randomised to the 24-week Tai chi exercise intervention group and 24-week health education control group. Global cognitive function and the specific domains of cognition (memory, processing speed, executive function, attention and verbal learning and memory) will be assessed at baseline and 12 and 24 weeks after randomisation. At the same time, fMRI and P300 will be measured the structure and function of brain regions related to cognitive function at baseline and 24 weeks after randomisation. Recruitment is currently ongoing (recruitment began on 9 November 2020). The approximate completion date for recruitment is in April 2021, and we anticipate to complete the study by December 2021.
Ethics and dissemination:
Ethics approval was given by the Medical Ethics Committee of the Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine (approval number: 2019-058-04). The findings will be disseminated through peer-reviewed publications and at scientific conferences.
Trial registration number:
ChiCTR2000033176; Pre-results.
Keywords: complementary medicine; neurology; protocols & guidelines; sports medicine.
PMID: 33558352 DOI: 10.1136/bmjopen-2020-042177